Joachim Aerts
- Relation of health-related quality of life, frequent exacerbation phenotype and circulating systemic biomarkers in stable COPDBy Daiana Stolz, Francesco Blasi, Renaud Louis, Wim Boersma, Alicia Lacoma, Kostantinos Kostikas, Paola Castellotti, Lucas Boeck, Branislava Milenkovic, Tobias Welte, Janko Rakic, Emiel Wouters, Joachim Aerts, Arturo Huerta, Markos Minas, Antoni Torres and Michael TammDaiana Stolz1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandFrancesco Blasi2IRCCS Policlinico Milan, University of Milan, Milan, ItalyRenaud Louis3Pneumology, University of Liege, Liege, BelgiumWim Boersma4Pneumology, Medisch Centrum, Alkmaar, NetherlandsAlicia Lacoma5Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainKostantinos Kostikas6Pneumology, University of Thessaly Medical School, Larissa, GreecePaola Castellotti2IRCCS Policlinico Milan, University of Milan, Milan, ItalyLucas Boeck1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandBranislava Milenkovic7Institute for Pulmonary Diseases, Clinical Centre of Serbia, Belgrade, SerbiaTobias Welte8Pneumology, Medizinische Hochschule Hannover, Hannover, GermanyJanko Rakic1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandEmiel Wouters9Pneumology, University Hospital Maastricht, Maastricht, NetherlandsJoachim Aerts10Pneumology, Amphia Hospital, Breda, NetherlandsArturo Huerta11Pneumology, Hospital Clinic, Barcelona, SpainMarkos Minas6Pneumology, University of Thessaly Medical School, Larissa, GreeceAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainMichael Tamm1Clinic of Pulmonary Medicine, University Hospital, Basel, Switzerland
- Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPDBy Daiana Stolz, Wim Boersma, Renaud Louis, Francesco Blasi, Branislava Milenkovic, Alicia Lacoma, Joachim Aerts, Vincent Heinen, Marilena Pappalettera, Kostantinos Kostikas, Cristina Prat, Emiel Wouters, Antoni Torres, Tobias Welte and Michael TammDaiana Stolz1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsRenaud Louis3Pneumology, University of Liege, Liege, BelgiumFrancesco Blasi4IRCCS Policlinico Milan, University of Milan, Milan, ItalyBranislava Milenkovic5Institute for Pulmonary Diseases, Clinical Centre, Serbia, SerbiaAlicia Lacoma6Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainJoachim Aerts7Pneumology, Amphia Hospital, Breda, NetherlandsVincent Heinen3Pneumology, University of Liege, Liege, BelgiumMarilena Pappalettera4IRCCS Policlinico Milan, University of Milan, Milan, ItalyKostantinos Kostikas8Pneumology, University of Thessaly Medical School, Larissa, GreeceCristina Prat6Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainEmiel Wouters9Pneumology, University Hospital Maastricht, Maastricht, NetherlandsAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule Hannover, Hannover, GermanyMichael Tamm1Clinic of Pulmonary Medicine, University Hospital, Basel, Switzerland
- Combined assessment according to the new GOLD guidelines and its relation to outcome in COPDBy Daiana Stolz, Kostantinos Kostikas, Francesco Blasi, Branislava Milenkovic, Wim Boersma, Joachim Aerts, Renaud Louis, Tobias Welte, Alicia Lacoma, Cristina Prat, Andreas Scherr, Janko Rakic, Marilena Pappalettera, Gernot Rohde, Antoni Torres, Sabine Hertel, Sven Giersdorf and Michael TammDaiana Stolz1Pneumology, University Hospital, Basel, SwitzerlandKostantinos Kostikas2University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi3Pneumology, IRCCS Policlinico, Milan, ItalyBranislava Milenkovic4Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaWim Boersma5Pneumology, Medisch Centrum, Alkmaar, NetherlandsJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsRenaud Louis7Pneumology, University of Liege, BelgiumTobias Welte8Pneumology, Medizinische Hochschule, Hannover, GermanyAlicia Lacoma9Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainCristina Prat9Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainAndreas Scherr1Pneumology, University Hospital, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital, Basel, SwitzerlandMarilena Pappalettera3Pneumology, IRCCS Policlinico, Milan, ItalyGernot Rohde10Pneumology, University Hospital, Maastricht, NetherlandsAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainSabine Hertel12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Pneumology, University Hospital, Basel, Switzerland
- Bacterial airway colonization is not associated with increased procalcitonin in stable COPDBy Daiana Stolz, Renaud Louis, Joachim Aerts, Tobias Welte, Alicia Lacoma, Wim Boersma, Kostantinos Kostikas, Francesco Blasi, Branislava Milenkovic, Cristina Prat, Janko Rakic, Lucas Boeck, Paola Castellotti, Gernot Rohde, Antoni Torres, Sabine Hertel, Sven Giersdorf and Michael TammDaiana Stolz1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandRenaud Louis2Pneumology, University of Liege, BelgiumJoachim Aerts3Pneumology, Amphia Hospital, Breda, NetherlandsTobias Welte4Pneumology, Medizinische Hochschule, Hannover, GermanyAlicia Lacoma5Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainWim Boersma6Pneumology, Medisch Centrum, Alkmaar, NetherlandsKostantinos Kostikas7University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi8Pneumology, IRCCS Policlinico, Milan, ItalyBranislava Milenkovic9Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaCristina Prat5Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainJanko Rakic1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandLucas Boeck1Clinic of Pulmonary Medicine, University Hospital, Basel, SwitzerlandPaola Castellotti8Pneumology, IRCCS Policlinico, Milan, ItalyGernot Rohde10Pneumology, University Hospital, Maastricht, NetherlandsAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainSabine Hertel12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Clinic of Pulmonary Medicine, University Hospital, Basel, Switzerland
- Proadrenomedullin improves the prognostic property of the BODE indexBy Daiana Stolz, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Renaud Louis, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Antoni Torres, Tobias Welte, Oliver Hartmann, Sven Giersdorf and Michael TammDaiana Stolz1Pneumology, University Hospital, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsRenaud Louis7Pneumology, University of Liege, BelgiumGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital, Basel, SwitzerlandAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyOliver Hartmann12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Pneumology, University Hospital, Basel, Switzerland
- The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infectionBy Daiana Stolz, Wim Boersma, Francesco Blasi, Renaud Louis, Joachim Aerts, Tobias Welte, Alicia Lacoma, Kostantinos Kostikas, Branislava Milenkovic, Alicia Marin, Janko Rakic, Lucas Boeck, Paola Castellotti, Gernot G.U. Rohde, Antoni Torres, Sabine Hertel, Sven Giersdorf and Michael TammDaiana Stolz1Clinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsFrancesco Blasi3Pneumology, IRCCS Policlinico, Milan, ItalyRenaud Louis4Pneumology, University of Liege, Liege, BelgiumJoachim Aerts5Pneumology, Amphia Hospital, Breda, NetherlandsTobias Welte6Pneumology, Medizinische Hochschule, Hannover, GermanyAlicia Lacoma7Microbiology, Hospital Universitari Germans Trias I Pujol, Badalona, SpainKostantinos Kostikas8University, Thessaly Medical School, Thessaloniki, GreeceBranislava Milenkovic9Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaAlicia Marin7Microbiology, Hospital Universitari Germans Trias I Pujol, Badalona, SpainJanko Rakic13Pneumology, Hospital of Aarau, Aarau, SwitzerlandLucas Boeck1Clinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, SwitzerlandPaola Castellotti3Pneumology, IRCCS Policlinico, Milan, ItalyGernot G.U. Rohde10Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, NetherlandsAntoni Torres11Pneumology, Hospital Clinic, Barcelona, SpainSabine Hertel12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanySven Giersdorf12Clinical Diagnosis, Thermo Scientific Biomarkers, Hennigsdorf, GermanyMichael Tamm1Clinic of Pneumology and Respiratory Cell Research, University Hospital, Basel, Switzerland
- Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPDBy Daiana Stolz, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr and Michael TammDaiana Stolz1Pneumology, University Hospital of Basel, Basel, SwitzerlandTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainRenaud Louis7Pneumology CHU Liege, University of Liege, Liege, BelgiumWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrad, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital of Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital of Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital of Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital of Basel, Basel, Switzerland
- COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter studyBy Daiana Stolz, Renaud Louis, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Marin, Lucas Boeck, Janko Rakic, Andreas Scherr, Antoni Torres, Tobias Welte and Michael TammDaiana Stolz1Pneumology, University Hospital of Basel, Basel, SwitzerlandRenaud Louis7Pneumology CHU Liege, University of Liege, Liege, BelgiumWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrad, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Marin9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital of Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital of Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital of Basel, Basel, SwitzerlandAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyMichael Tamm1Pneumology, University Hospital of Basel, Basel, Switzerland
- COPD on anti-GERD therapy remains at higher risk for severe exacerbationBy Daiana Stolz, Francesco Blasi, Joachim Aerts, Renaud Louis, Branislava Milenkovic, Kostantinos Kostikas, Tobias Welte, Antoni Torres, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Wim Boersma and Michael TammDaiana Stolz1Pneumology, University Hospital of Basel, Basel, SwitzerlandFrancesco Blasi5Pneumology, IRCCS Policlinico, Milan, ItalyJoachim Aerts6Pneumology, Amphia Hospital, Breda, NetherlandsRenaud Louis7Pneumology CHU Liege, University of Liege, Liege, BelgiumBranislava Milenkovic3Pneumology, Institute for Pulmonary Diseases, Belgrad, SerbiaKostantinos Kostikas4University, Thessaly Medical School, Thessaloniki, GreeceTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainGernot Rohde8Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital of Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital of Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital of Basel, Basel, SwitzerlandWim Boersma2Pneumology, Medisch Centrum, Alkmaar, NetherlandsMichael Tamm1Pneumology, University Hospital of Basel, Basel, Switzerland
- Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacityBy Jyotshna Mandal, Michael Roth, Eleni Papakonstantinou, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte and Daiana StolzJyotshna Mandal1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Roth1Pneumology, University Hospital Basel, Basel, SwitzerlandEleni Papakonstantinou1Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital Basel, Basel, SwitzerlandLucas Boeck1Pneumology, University Hospital Basel, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital Basel, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital Basel, Basel, SwitzerlandRenaud Louis2Pneumology, University of Liege, Liege, BelgiumBranislava Milencovic3Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaWim Boersma4Pneumology, Medisch Centrum, Alkmaar, NetherlandsKonstantinos Kostikas5Pneumology, Medical School, University of Thessaly, Larisa, GreeceFrancesco Blasi6Pneumology, IRCCS Policlinico Milan, Milan, ItalyJoachim Aerts7Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde8Pneumology, University Hospital Maastricht, Maastricht, NetherlandsAlicia Lacoma9Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainAntoni Torres10Pneumology, Hospital Clinic, Barcelona, SpainTobias Welte11Pneumology, Medizinische Hochschule, Hannover, GermanyDaiana Stolz1Pneumology, University Hospital Basel, Basel, Switzerland
- LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE studyBy Daiana Stolz, Jacob Hull Kristensen, Diana Julie Leeming, Morten Asser Karsdal, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr and Michael TammDaiana Stolz1Pneumology, University Hospital, Basel, SwitzerlandJacob Hull Kristensen12Biomarkers and Research, Nordic Bioscience, Herlev, DenmarkDiana Julie Leeming12Biomarkers and Research, Nordic Bioscience, Herlev, DenmarkMorten Asser Karsdal12Biomarkers and Research, Nordic Bioscience, Herlev, DenmarkTobias Welte2Pneumology, Medizinische Hochschule, Hannover, GermanyAntoni Torres3Pneumology, Hospital Clinic, Barcelona, SpainRenaud Louis4Pneumology, University Hospital, Liege, BelgiumWim Boersma5Pneumology, Medisch Centrum, Alkmaar, NetherlandsBranislava Milenkovic6Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaKonstantinos Kostikas7Pneumology, Thessaly Medical School, Thessaloniki, GreeceFrancesco Blasi8Pneumology, IRCCS Polyclinico, Milan, ItalyJoachim Aerts9Pneumology, Amphia Hospital, Breda, NetherlandsGernot Rohde10Pneumology, University Hospital, Maastricht, NetherlandsAlicia Lacoma11Microbiology, Hospital Universitari Germans Trais i Pujol, Badalona, SpainLucas Boeck1Pneumology, University Hospital, Basel, SwitzerlandJanko Rakic1Pneumology, University Hospital, Basel, SwitzerlandAndreas Scherr1Pneumology, University Hospital, Basel, SwitzerlandMichael Tamm1Pneumology, University Hospital, Basel, Switzerland
- Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk indexBy Lucas Boeck, Kostantinos Kostikas, Francesco Blasi, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim Aerts, Tobias Welte, Antoni Torres, Gernot Rohde, Janko Rakic, Andreas Scherr, Michael Koller, Michael Tamm and Daiana StolzLucas Boeck1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandKostantinos Kostikas2Department of Pneumology, University Thessaly Medical School, Larissa, GreeceFrancesco Blasi3Department of Pathophysiology and Transplantation, Universita' degli Studi di Milano, Milan, ItalyWim Boersma4Department of Pneumology, Medisch Centrum Alkmaar, Alkmaar, NetherlandsBranislava Milenkovic5Clinic for Pulmonary Diseases, Faculty of Medicine, University of Belgrade, Belgrade, SerbiaAlicia Lacoma6Department of Microbiology, Hospital Universitari Germans Trias i Pujol, Badalona, SpainRenaud Louis7Department of Pneumology, CHU Liege, University of Liege, GIGAI Research Group, Liege, BelgiumJoachim Aerts8Department of Pneumology, Amphia Hospital/Erasmus MC, Breda, NetherlandsTobias Welte9Department of Pneumology, Medizinische Hochschule Hannover, Hannover, GermanyAntoni Torres10Department of Pneumology, Hospital Clinic - IDIBAPS, Ciber de Enfermedades Respiratorias, Barcelona, SpainGernot Rohde11Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, NetherlandsJanko Rakic1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandAndreas Scherr1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandMichael Koller12Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, SwitzerlandMichael Tamm1Department of Pneumology, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Department of Pneumology, University Hospital Basel, Basel, Switzerland
- Mannose binding lectin - HYPD allele is associated with frequent exacerbation in COPD patientsBy Bijaya Malla, Jyotshna Mandal, Luigi Costa, Rudi Steffensen, Adrian Egli, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm, Michael Roth and Daiana StolzBijaya Malla1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandJyotshna Mandal1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandLuigi Costa1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandRudi Steffensen2Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandAdrian Egli3Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandTobias Welte4Department of Clinical Immunology, Aalborg University Hospital, Aalborg, DenmarkAntoni Torres5Infection Biology, Department of Biomedicine, University of Basel, Basel, SwitzerlandRenaud Louis6Pneumology, Medizinische Hochschule, Hannover, GermanyWim Boersma7Pneumology, Hospital Clinic, Barcelona, SpainBranislava Milenkovic8Pneumology, University of Liege, Liege, BelgiumKostantinos Kostikas9Pneumology, Medisch Centrum, Alkmaar, NetherlandsFrancesco Blasi10Pneumology, Institute for Pulmonary Diseases, Belgrade, SerbiaJoachim Aerts11Pneumology, Thessaly Medical School, Thessaloniki, GreeceGernot Rohde12Pneumology, IRCCS Policlinico, Milan, ItalyAlicia Lacoma13Pneumology, Amphia Hospital, Breda, NetherlandsLucas Boeck14Pneumology, University Hospital, Maastricht, NetherlandsJanko Rakic14Pneumology, University Hospital, Maastricht, NetherlandsAndreas Scherr14Pneumology, University Hospital, Maastricht, NetherlandsMichael Tamm14Pneumology, University Hospital, Maastricht, NetherlandsMichael Roth1Pulmonary Cell Research and Pneumology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandDaiana Stolz14Pneumology, University Hospital, Maastricht, Netherlands
- Prognostic assessment in COPD without lung function: the B-AE-D indicesBy Lucas Boeck, Joan B. Soriano, Marjolein Brusse-Keizer, Francesco Blasi, Konstantinos Kostikas, Wim Boersma, Branislava Milenkovic, Renaud Louis, Alicia Lacoma, Remco Djamin, Joachim Aerts, Antoni Torres, Gernot Rohde, Tobias Welte, Pablo Martinez-Camblor, Janko Rakic, Andreas Scherr, Michael Koller, Job van der Palen, Jose M. Marin, Inmaculada Alfageme, Pere Almagro, Ciro Casanova, Cristobal Esteban, Juan J. Soler-Cataluña, Juan P. de Torres, Marc Miravitlles, Bartolome R. Celli, Michael Tamm and Daiana StolzArticle | Published in 2016 in European Respiratory JournalLucas Boeck1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandJoan B. Soriano2Instituto de Investigación Hospital Universitario de la Princesa (IISP), Universidad Autónoma de Madrid, Cátedra UAM-Linde, Madrid, SpainMarjolein Brusse-Keizer3Medical School Twente, Medisch Spectrum Twente, Enschede, The NetherlandsFrancesco Blasi4Dept of Pathophysiology and Transplantation, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Cà Granda, Milan, ItalyKonstantinos Kostikas5University of Thessaly Medical School, Larissa, GreeceWim Boersma6Dept of Pneumology, Medisch Centrum, Alkmaar, The NetherlandsBranislava Milenkovic7Faculty of Medicine, University of Belgrade, Belgrade, Serbia8Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Belgrade, SerbiaRenaud Louis9Dept of Pneumology, University of Liege, Liege, BelgiumAlicia Lacoma10Dept of Microbiology, Hospital Universitari Germans Trias i Pujol, CIBER Enfermedades Respiratorias, Badalona, SpainRemco Djamin11Dept of Pneumology, Amphia Hospital, Breda, The NetherlandsJoachim Aerts11Dept of Pneumology, Amphia Hospital, Breda, The NetherlandsAntoni Torres12Dept of Pneumology, Hospital Clinic, Barcelona, SpainGernot Rohde13Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The NetherlandsTobias Welte14Dept of Pneumology, Medizinische Hochschule, Hannover, GermanyPablo Martinez-Camblor15Universidad Autónoma de Chile, Santiago, ChileJanko Rakic1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandAndreas Scherr1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandMichael Koller16Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, SwitzerlandJob van der Palen3Medical School Twente, Medisch Spectrum Twente, Enschede, The NetherlandsJose M. Marin17Respiratory Dept, Hospital Universitario Miguel Servet, Zaragoza, SpainInmaculada Alfageme18Respiratory Dept, Valme University Hospital, Seville, SpainPere Almagro19Internal Medicine Unit, Hospital Universitari Mútua de Terrassa, Barcelona, SpainCiro Casanova20Respiratory Dept, Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, SpainCristobal Esteban21Respiratory Dept, Hospital Galdakao-Usansolo, Bizkaia, SpainJuan J. Soler-Cataluña22Respiratory Unit, Hospital General de Requena, Valencia, SpainJuan P. de Torres23Respiratory Dept, Clínica Universidad de Navarra, Pamplona, SpainMarc Miravitlles24Pneumology Dept, Hospital Universitari Vall d'Hebron, Barcelona, SpainBartolome R. Celli25Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard University, Boston, MA, USAMichael Tamm1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital, Basel, Switzerland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
